Skip to content

The construction and application of a sarcopenia-oriented precise diagnosis and treatment system for esophageal cancer

The construction and application of a sarcopenia-oriented precise diagnosis and treatment system for esophageal cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058008
Enrollment
Unknown
Registered
2022-03-26
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

Intervention group:Oral nutritional support + exercise
Control group:Routine treatment

Sponsors

Huai 'an First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years; 2. Gastric cancer or colorectal cancer (tumor diagnosis requires a pathological report) and planed to perform surgical treatment; 3. No contraindications of enteral nutrition; 4. Signe the patient's informed consent and be willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled or severe heart, liver, lung and kidney disease; 2. Patients who have a history of stroke, epilepsy, primary brain tumor or tumor brain metastases and are unable to communicate with language; 3. Patients with coagulation dysfunction or other blood diseases; 4. Emergency surgery; 5. Patients unable to conduct exercise intervention due to physical disability or mental disorder; 6. Allergic patients to perioperative ONS nutrition; 7. Patients with other malignant diseases; 8. Patients who are not expected to obtain follow-up data.

Design outcomes

Primary

MeasureTime frame
Perioperative complication rate;Length of hospital stay after operation;Incidence of sarcopenia;Short-term postoperative quality of life;

Countries

China

Contacts

Public ContactTian Wenze

Huai 'an First Affiliated Hospital of Nanjing Medical University

tianwenze@qq.com+86 15861717186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026